ResearcherChinese PLA General HospitalNo recent work listed

Xian-Jie Shi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9758-2403; OpenAlex author ID A5101950810. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis. Last author DOI 10.1016/j.asjsur.2021.11.048 ↗
Generation and application of patient-derived xenograft models in pancreatic cancer research. First author DOI 10.1097/cm9.0000000000000524 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chengfang Wang · 1 shared paper, 2019 · strength 0.20
- Paper Generation and application of patient-derived xenograft models in pancreatic cancer research. DOI 10.1097/cm9.0000000000000524 ↗
Yang Sun · 1 shared paper, 2022 · strength 0.19
- Paper Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis. DOI 10.1016/j.asjsur.2021.11.048 ↗
Xiao-Dong Huang · 1 shared paper, 2022 · strength 0.19
- Paper Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis. DOI 10.1016/j.asjsur.2021.11.048 ↗
Fengjun Xiao · 1 shared paper, 2022 · strength 0.19
- Paper Protein tyrosine phosphatase 1 protects human pancreatic cancer from erastin-induced ferroptosis. DOI 10.1016/j.asjsur.2021.11.048 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.